申请人:Chengdu Baiyu Pharmaceutical Co., Ltd.
公开号:EP4137491A1
公开(公告)日:2023-02-22
The present application relates to imidazolidinone derivatives and medical use thereof, and in particular relates to pyrimidine derivatives represented by general formula (I), or stereoisomers, solvates, metabolites, prodrugs, pharmaceutically acceptable salts or co-crystals thereof, a pharmaceutical composition comprising the same, and use of the compound or pharmaceutical composition according to the present application in the manufacture of a medicament for treatment of cancer.
本申请涉及咪唑烷酮衍生物及其医药用途,特别是涉及由一般式(I)表示的嘧啶衍生物,或者其立体异构体、溶剂化物、代谢物、前药、药学上可接受的盐或共晶,包含所述化合物的药物组合物,以及根据本申请的化合物或药物组合物在制备用于治疗癌症的药物中的用途。